Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 7, 2006 - Issue 13
Submit an article Journal homepage
113
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Nelarabine in the treatment of refractory T-cell malignant diseases

Justin Kline Section of Hematology/Oncology, Department of Medicine and Cancer Research Center,University of Chicago, Chicago, IL, USA. [email protected]
&
Richard A Larson Section of Hematology/Oncology, Department of Medicine and Cancer Research Center,University of Chicago, Chicago, IL, USA. [email protected]
Pages 1791-1799 | Published online: 23 Aug 2006

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

WilliamR. Waud, KarenS. Gilbert & JohnA. Secrist$suffix/text()$suffix/text(). (2012) Preclinical Antitumor Activity of Thiarabine in Human Leukemia and Lymphoma Xenograft Models. Nucleosides, Nucleotides & Nucleic Acids 31:9, pages 647-660.
Read now

Articles from other publishers (3)

Abdiganiyeva S. R. Tillyashaykhov M. N. Abdurakhmonov D. A. Tuidzhanova Kh. Kh.. (2019) THE STUDY OF CELLULAR FACTORS OF IMMUNITY IN PATIENTS WITH NON-HODGKIN'S LYMPHOMAS. Science Review:6(23), pages 3-7.
Crossref
Richard A. Larson. (2007) Three New Drugs for Acute Lymphoblastic Leukemia: Nelarabine, Clofarabine, and Forodesine. Seminars in Oncology 34, pages S13-S20.
Crossref
Alex H. Beesley, Misty‐Lee Palmer, Jette Ford, Renae E. Weller, Aaron J. Cummings, Joseph R. Freitas, Martin J. Firth, Kanchana U. Perera, Nicholas H. De Klerk & Ursula R. Kees. (2007) In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia . British Journal of Haematology 137:2, pages 109-116.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.